diABZI was also tagged to CD47/PD-L1 targeting nanoparticles for intratumoral injection into a mouse glioblastoma model, leading to improved T cell infiltration in the brain and synergy with radiation delivered as 9 Gy in three fractions, using survival as the endpoint (Zhang et al., 2023). Here, CD274 is linked to glioblastoma.